Literature DB >> 23824894

Mouse model of Staphylococcus aureus skin infection.

Natalia Malachowa1, Scott D Kobayashi, Kevin R Braughton, Frank R DeLeo.   

Abstract

Bacterial skin and soft tissue infections are abundant worldwide and many are caused by Staphylococcus aureus. Indeed, S. aureus is the leading cause of skin and soft tissue infections in the USA. Here, we describe a mouse model of skin and soft tissue infection induced by subcutaneous inoculation of S. aureus. This animal model can be used to investigate a number of factors related to the pathogenesis of skin and soft tissue infections, including strain virulence and the contribution of specific bacterial molecules to disease, and it can be employed to test the potential effectiveness of antibiotic therapies or vaccine candidates.

Entities:  

Mesh:

Year:  2013        PMID: 23824894     DOI: 10.1007/978-1-62703-481-4_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  25 in total

1.  Isolation of Infiltrating Leukocytes from Mouse Skin Using Enzymatic Digest and Gradient Separation.

Authors:  Charles J Benck; Tijana Martinov; Brian T Fife; Devavani Chatterjea
Journal:  J Vis Exp       Date:  2016-01-25       Impact factor: 1.355

2.  Generation of a Stable Plasmid for In Vitro and In Vivo Studies of Staphylococcus Species.

Authors:  Christina N Krute; Kelsey L Krausz; Mary A Markiewicz; Jason A Joyner; Srijana Pokhrel; Pamela R Hall; Jeffrey L Bose
Journal:  Appl Environ Microbiol       Date:  2016-09-16       Impact factor: 4.792

3.  ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation.

Authors:  Seth M Daly; Bradley O Elmore; Jeffrey S Kavanaugh; Kathleen D Triplett; Mario Figueroa; Huzefa A Raja; Tamam El-Elimat; Heidi A Crosby; Jon K Femling; Nadja B Cech; Alexander R Horswill; Nicholas H Oberlies; Pamela R Hall
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 4.  Mouse models for infectious diseases caused by Staphylococcus aureus.

Authors:  Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  J Immunol Methods       Date:  2014-04-24       Impact factor: 2.303

5.  MroQ Is a Novel Abi-Domain Protein That Influences Virulence Gene Expression in Staphylococcus aureus via Modulation of Agr Activity.

Authors:  Stephanie Marroquin; Brittney Gimza; Brooke Tomlinson; Michelle Stein; Andrew Frey; Rebecca A Keogh; Rachel Zapf; Daniel A Todd; Nadja B Cech; Ronan K Carroll; Lindsey N Shaw
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

6.  The good side of inflammation: Staphylococcus aureus proteins SpA and Sbi contribute to proper abscess formation and wound healing during skin and soft tissue infections.

Authors:  Cintia D Gonzalez; Camila Ledo; Eliana Cela; Inés Stella; Chunliang Xu; Diego S Ojeda; Paul S Frenette; Marisa I Gómez
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-07-09       Impact factor: 5.187

7.  Innate Sex Bias of Staphylococcus aureus Skin Infection Is Driven by α-Hemolysin.

Authors:  Moriah J Castleman; Srijana Pokhrel; Kathleen D Triplett; Donna F Kusewitt; Bradley O Elmore; Jason A Joyner; Jon K Femling; Geetanjali Sharma; Helen J Hathaway; Eric R Prossnitz; Pamela R Hall
Journal:  J Immunol       Date:  2017-12-08       Impact factor: 5.422

Review 8.  Host factors that contribute to recurrent staphylococcal skin infection.

Authors:  Christopher P Montgomery; Michael Z David; Robert S Daum
Journal:  Curr Opin Infect Dis       Date:  2015-06       Impact factor: 4.915

9.  Identification of the Staphylococcus aureus vfrAB operon, a novel virulence factor regulatory locus.

Authors:  Jeffrey L Bose; Seth M Daly; Pamela R Hall; Kenneth W Bayles
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

10.  CD36 Is Essential for Regulation of the Host Innate Response to Staphylococcus aureus α-Toxin-Mediated Dermonecrosis.

Authors:  Moriah J Castleman; Maria Febbraio; Pamela R Hall
Journal:  J Immunol       Date:  2015-07-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.